Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25840
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrinivasan, Ashish-
dc.contributor.authorvan Langenberg, Daniel-
dc.contributor.authorDe Cruz, Peter P-
dc.date2021-02-11-
dc.date.accessioned2021-02-16T01:07:05Z-
dc.date.available2021-02-16T01:07:05Z-
dc.date.issued2021-05-
dc.identifier.citationInflammatory Bowel Diseases 2021; 27(6): e69en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25840-
dc.language.isoeng-
dc.subjectCrohn diseaseen
dc.subjectdose intensificationen
dc.subjectloss of responseen
dc.subjectustekinumaben
dc.titleReal-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleInflammatory Bowel Diseasesen
dc.identifier.affiliationMonash University, Department of Medicine, Melbourne, Australiaen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationDepartment of Gastroenterology, Eastern Health, Melbourne, Australiaen
dc.identifier.affiliationGastroenterology and Hepatologyen
dc.identifier.doi10.1093/ibd/izab018en
dc.type.contentTexten
dc.identifier.pubmedid33570129-
local.name.researcherDe Cruz, Peter P
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

72
checked on Oct 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.